NCT00304226View on ClinicalTrials.gov

Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

1,288

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Hypertension
Interventions
DRUG

valsartan

DRUG

amlodipine

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00304226 - Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy | Biotech Hunter | Biotech Hunter